Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm

doi:10.1016/j.avsg.2006.11.001

Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Ann Vasc Surg. Author manuscript; available in PMC 2008 May 1.

Published in final edited form as:

Ann Vasc Surg. 2007 May; 21(3): 392–401.

doi: 10.1016/j.avsg.2006.11.001

PMCID: PMC2128752

NIHMSID: NIHMS34953

Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm

Faisal Aziz, MD¹ and Helena Kuivaniemi, MD, PhD^2,³

Author information ► Copyright and License information ►

The publisher's final edited version of this article is available at Ann Vasc Surg

See other articles in PMC that cite the published article.

Abstract

Abdominal aortic aneurysm (AAA) is a significant health problem in the United States with approximately 30,000 repair operations annually. Treatment of AAA is associated with more than 150,000 hospital admissions per year. The development of AAA is characterized by destruction of the elastic media of the aortic wall. A large body of evidence suggests that a group of enzymes called matrix metalloproteinases (MMPs) plays a significant role in the destruction of extracellular matrix in the aortic wall. MMP inhibition has, therefore, been viewed as an alternative pharmacotherapeutic approach to slow down the development and progression of small AAAs thus reducing the need for surgical intervention.

Keywords: Abdominal Aortic Aneurysm, Matrix Metalloproteinases, Matrix Metalloproteinase Inhibitors, Doxycycline, Small Molecule Inhibitors

Related citations in PubMed

Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. [Curr Med Res Opin. 2004]
Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP, Liapis CD. Curr Med Res Opin. 2004 Apr; 20(4):419-32.
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. [J Vasc Surg. 1996]
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.
Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. J Vasc Surg. 1996 Feb; 23(2):336-46.
MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. [Ann N Y Acad Sci. 1999]
MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Thompson RW, Baxter BT. Ann N Y Acad Sci. 1999 Jun 30; 878:159-78.
Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content. [J Vasc Surg. 2009]
Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Abdul-Hussien H, Hanemaaijer R, Verheijen JH, van Bockel JH, Geelkerken RH, Lindeman JH. J Vasc Surg. 2009 Mar; 49(3):741-9.
Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature. [Curr Vasc Pharmacol. 2011]
Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature.
Dodd BR, Spence RA. Curr Vasc Pharmacol. 2011 Jul 1; 9(4):471-8.

See reviews... See all...

Cited by other articles in PMC

25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients [BMC Nephrology. ]
25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients
Wasse H, Cardarelli F, De Staercke C, Hooper C, Veledar E, Guessous I. BMC Nephrology. 1224
Binding Sites for Ets Family of Transcription Factors Dominate the Promoter Regions of Differentially Expressed Genes in Abdominal Aortic Aneurysms [Circulation. Cardiovascular genetics. 2009]
Binding Sites for Ets Family of Transcription Factors Dominate the Promoter Regions of Differentially Expressed Genes in Abdominal Aortic Aneurysms
Nischan J, Gatalica Z, Curtis M, Lenk GM, Tromp G, Kuivaniemi H. Circulation. Cardiovascular genetics. 2009 Dec; 2(6)565-572
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease [Journal of human genetics. 2010]
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease
Shimizu C, Matsubara T, Onouchi Y, Jain S, Sun S, Nievergelt CM, Shike H, Brophy VH, Takegawa T, Furukawa S, Akagi T, Newburger JW, Baker AL, Burgner D, Hibberd ML, Davila S, Levin M, Mamtani M, He W, Ahuja SK, Burns JC. Journal of human genetics. 2010 Dec; 55(12)779-784
Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm [Annals of surgery. 2009]
Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm
Zhang F, Kent KC, Yamanouchi D, Zhang Y, Kato K, Tsai S, Nowygrod R, Schmidt AM, Liu B. Annals of surgery. 2009 Sep; 250(3)416-423

See all...

Recent activity

Clear Turn Off Turn On

Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneur...
Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm
Annals of vascular surgery. 2007 May; 21(3)392-401

PMC
The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a revi...
The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review.
Clin Exp Rheumatol. 2008 Jan-Feb ;26(1):139-45.

PubMed
Aggrecanases and cartilage matrix degradation.
Aggrecanases and cartilage matrix degradation.
Arthritis Res Ther. 2003 ;5(2):94-103. Epub 2003 Feb 14 .

PubMed
A citrus flavonoid, nobiletin, suppresses production and gene expression of matr...
A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts.
J Rheumatol. 2000 Jan ;27(1):20-5.

PubMed
Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-ki...
Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells.
Cancer Res. 2002 Feb 15 ;62(4):1025-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Review Current concepts in the pathogenesis of abdominal aortic aneurysm. [J Vasc Surg. 2003]

Ailawadi G, Eliason JL, Upchurch GR Jr

J Vasc Surg. 2003 Sep; 38(3):584-8.
Review Abdominal aortic aneurysm. [N Engl J Med. 1993]

Ernst CB

N Engl J Med. 1993 Apr 22; 328(16):1167-72.
Detection and management of small aortic aneurysms. [N Engl J Med. 2002]

Thompson RW

N Engl J Med. 2002 May 9; 346(19):1484-6.
Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. [Arterioscler Thromb Vasc Biol. 1996]

Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, Kuller LH, O'Leary D

Arterioscler Thromb Vasc Biol. 1996 Aug; 16(8):963-70.

Review Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. [J Vasc Surg. 2003]

Brewster DC, Cronenwett JL, Hallett JW Jr, Johnston KW, Krupski WC, Matsumura JS, Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery

J Vasc Surg. 2003 May; 37(5):1106-17.

Review Could medical intervention work for aortic aneurysms? [Am J Surg. 2004]

Baxter BT

Am J Surg. 2004 Dec; 188(6):628-32.
Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. [J Vasc Surg. 2002]

Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, Baxter BT

J Vasc Surg. 2002 May; 35(5):923-9.
Abdominal aortic aneurysm regression by medical treatment: possibility or pipe dream? [J Vasc Surg. 2006]

Baxter BT

J Vasc Surg. 2006 May; 43(5):1068-9.

Review Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? [Circ Res. 2001]

Creemers EE, Cleutjens JP, Smits JF, Daemen MJ

Circ Res. 2001 Aug 3; 89(3):201-10.
Review Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium. [Ann Med. 2001]

Wilson EM, Spinale FG

Ann Med. 2001 Dec; 33(9):623-34.
Review An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. [Vasc Endovascular Surg. 2005]

Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML

Vasc Endovascular Surg. 2005 Nov-Dec; 39(6):457-64.

Review Current concepts in the pathogenesis of abdominal aortic aneurysm. [J Vasc Surg. 2003]

Ailawadi G, Eliason JL, Upchurch GR Jr

J Vasc Surg. 2003 Sep; 38(3):584-8.
Review Abdominal aortic aneurysm. [N Engl J Med. 1993]

Ernst CB

N Engl J Med. 1993 Apr 22; 328(16):1167-72.
Review Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. [Curr Med Res Opin. 2004]

Kadoglou NP, Liapis CD

Curr Med Res Opin. 2004 Apr; 20(4):419-32.
Review Reflections on the pathogenesis of abdominal aortic aneurysms. [Cardiovasc Surg. 2002]

Thompson RW

Cardiovasc Surg. 2002 Aug; 10(4):389-94.
Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. [Am J Pathol. 1997]

López-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW

Am J Pathol. 1997 Mar; 150(3):993-1007.
Gender differences in experimental aortic aneurysm formation. [Arterioscler Thromb Vasc Biol. 2004]

Ailawadi G, Eliason JL, Roelofs KJ, Sinha I, Hannawa KK, Kaldjian EP, Lu G, Henke PK, Stanley JC, Weiss SJ, Thompson RW, Upchurch GR Jr

Arterioscler Thromb Vasc Biol. 2004 Nov; 24(11):2116-22.
Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. [Surgery. 1997]

Tamarina NA, McMillan WD, Shively VP, Pearce WH

Surgery. 1997 Aug; 122(2):264-71; discussion 271-2.
Elastase-induced experimental aneurysms in rats. [Circulation. 1990]

Anidjar S, Salzmann JL, Gentric D, Lagneau P, Camilleri JP, Michel JB

Circulation. 1990 Sep; 82(3):973-81.
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. [J Clin Invest. 2000]

Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW

J Clin Invest. 2000 Jun; 105(11):1641-9.

Review Matrix metalloproteinases. [Br J Surg. 1997]

Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ

Br J Surg. 1997 Feb; 84(2):160-6.
Review Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. [Circ Res. 2003]

Visse R, Nagase H

Circ Res. 2003 May 2; 92(8):827-39.

Review Matrix metalloproteinases. [Br J Surg. 1997]

Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ

Br J Surg. 1997 Feb; 84(2):160-6.
Review Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. [Circ Res. 2003]

Visse R, Nagase H

Circ Res. 2003 May 2; 92(8):827-39.
Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2). [J Biol Chem. 2003]

Trexler M, Briknarová K, Gehrmann M, Llinás M, Patthy L

J Biol Chem. 2003 Apr 4; 278(14):12241-6.

Review Matrix metalloproteinases. [Br J Surg. 1997]

Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ

Br J Surg. 1997 Feb; 84(2):160-6.
Review Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. [Circ Res. 2003]

Visse R, Nagase H

Circ Res. 2003 May 2; 92(8):827-39.
Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. [J Vasc Surg. 2002]

Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, Baxter BT

J Vasc Surg. 2002 May; 35(5):923-9.
Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. [Surgery. 1997]

Tamarina NA, McMillan WD, Shively VP, Pearce WH

Surgery. 1997 Aug; 122(2):264-71; discussion 271-2.
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. [Arterioscler Thromb Vasc Biol. 1995]

Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT

Arterioscler Thromb Vasc Biol. 1995 Aug; 15(8):1145-51.
Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. [Ann Vasc Surg. 1999]

Mao D, VanVickle SJ, Curci JA, Thompson RW

Ann Vasc Surg. 1999 Mar; 13(2):236-7.
Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. [Biochem Biophys Res Commun. 1999]

Mao D, Lee JK, VanVickle SJ, Thompson RW

Biochem Biophys Res Commun. 1999 Aug 11; 261(3):904-10.
Review Role of matrix metalloproteinases in abdominal aortic aneurysms. [Ann N Y Acad Sci. 1996]

Thompson RW, Parks WC

Ann N Y Acad Sci. 1996 Nov 18; 800():157-74.

Size matters: the relationship between MMP-9 expression and aortic diameter. [Circulation. 1997]

McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH

Circulation. 1997 Oct 7; 96(7):2228-32.
In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. [Arterioscler Thromb Vasc Biol. 1995]

McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearce WH

Arterioscler Thromb Vasc Biol. 1995 Aug; 15(8):1139-44.
Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak. [J Vasc Surg. 2002]

Lorelli DR, Jean-Claude JM, Fox CJ, Clyne J, Cambria RA, Seabrook GR, Towne JB

J Vasc Surg. 2002 May; 35(5):916-22.
Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. [Circulation. 2001]

Sangiorgi G, D'Averio R, Mauriello A, Bondio M, Pontillo M, Castelvecchio S, Trimarchi S, Tolva V, Nano G, Rampoldi V, Spagnoli LG, Inglese L

Circulation. 2001 Sep 18; 104(12 Suppl 1):I288-95.
Review Could medical intervention work for aortic aneurysms? [Am J Surg. 2004]

Baxter BT

Am J Surg. 2004 Dec; 188(6):628-32.
Abdominal aortic aneurysm regression by medical treatment: possibility or pipe dream? [J Vasc Surg. 2006]

Baxter BT

J Vasc Surg. 2006 May; 43(5):1068-9.
MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. [Ann N Y Acad Sci. 1999]

Thompson RW, Baxter BT

Ann N Y Acad Sci. 1999 Jun 30; 878():159-78.

How do tetracyclines work? [Adv Dent Res. 1998]

Ryan ME, Ashley RA

Adv Dent Res. 1998 Nov; 12(2):149-51.
Review Tetracyclines: nonantibiotic properties and their clinical implications. [J Am Acad Dermatol. 2006]

Sapadin AN, Fleischmajer R

J Am Acad Dermatol. 2006 Feb; 54(2):258-65.

Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. [Adv Dent Res. 1998]

Hanemaaijer R, Visser H, Koolwijk P, Sorsa T, Salo T, Golub LM, van Hinsbergh VW

Adv Dent Res. 1998 Nov; 12(2):114-8.
How do tetracyclines work? [Adv Dent Res. 1998]

Ryan ME, Ashley RA

Adv Dent Res. 1998 Nov; 12(2):149-51.
Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. [J Vasc Surg. 2002]

Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, Baxter BT

J Vasc Surg. 2002 May; 35(5):923-9.
Localized administration of doxycycline suppresses aortic dilatation in an experimental mouse model of abdominal aortic aneurysm. [Ann Vasc Surg. 2006]

Bartoli MA, Parodi FE, Chu J, Pagano MB, Mao D, Baxter BT, Buckley C, Ennis TL, Thompson RW

Ann Vasc Surg. 2006 Mar; 20(2):228-36.
Suppression of experimental aneurysmal degeneration with chemically modified tetracycline derivatives. [Ann N Y Acad Sci. 1996]

Petrinec D, Holmes DR, Liao S, Golub LM, Thompson RW

Ann N Y Acad Sci. 1996 Nov 18; 800():263-5.
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. [J Clin Invest. 2000]

Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW

J Clin Invest. 2000 Jun; 105(11):1641-9.
Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. [Ann N Y Acad Sci. 1994]

Uitto VJ, Firth JD, Nip L, Golub LM

Ann N Y Acad Sci. 1994 Sep 6; 732():140-51.
Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. [Arthritis Rheum. 1996]

Smith GN Jr, Brandt KD, Hasty KA

Arthritis Rheum. 1996 Feb; 39(2):235-44.

Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. [J Surg Res. 1996]

Holmes DR, Petrinec D, Wester W, Thompson RW, Reilly JM

J Surg Res. 1996 Jun; 63(1):305-9.

Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). [J Vasc Surg. 1999]

Moore G, Liao S, Curci JA, Starcher BC, Martin RL, Hendricks RT, Chen JJ, Thompson RW

J Vasc Surg. 1999 Mar; 29(3):522-32.
The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. [J Vasc Surg. 1999]

Bigatel DA, Elmore JR, Carey DJ, Cizmeci-Smith G, Franklin DP, Youkey JR

J Vasc Surg. 1999 Jan; 29(1):130-8; discussion 138-9.
Amlodipine potentiates metalloproteinase activity and accelerates elastin degradation in a model of aneurysmal disease. [Eur J Vasc Endovasc Surg. 1998]

Boyle JR, Loftus IM, Goodall S, Crowther M, Bell PR, Thompson MM

Eur J Vasc Endovasc Surg. 1998 Nov; 16(5):408-14.
Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. [J Vasc Surg. 1998]

Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW

J Vasc Surg. 1998 Dec; 28(6):1082-93.
Rapamycin suppresses experimental aortic aneurysm growth. [J Vasc Surg. 2004]

Lawrence DM, Singh RS, Franklin DP, Carey DJ, Elmore JR

J Vasc Surg. 2004 Aug; 40(2):334-8.

Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. [Arterioscler Thromb Vasc Biol. 2003]

Luan Z, Chase AJ, Newby AC

Arterioscler Thromb Vasc Biol. 2003 May 1; 23(5):769-75.
HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. [J Biomed Sci. 2003]

Huang KC, Chen CW, Chen JC, Lin WW

J Biomed Sci. 2003 Jul-Aug; 10(4):396-405.
A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. [J Vasc Surg. 2002]

Nagashima H, Aoka Y, Sakomura Y, Sakuta A, Aomi S, Ishizuka N, Hagiwara N, Kawana M, Kasanuki H

J Vasc Surg. 2002 Jul; 36(1):158-63.
Simvastatin suppresses experimental aortic aneurysm expansion. [J Vasc Surg. 2006]

Kalyanasundaram A, Elmore JR, Manazer JR, Golden A, Franklin DP, Galt SW, Zakhary EM, Carey DJ

J Vasc Surg. 2006 Jan; 43(1):117-24.

Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms. [Ann Vasc Surg. 2006]

Parodi FE, Mao D, Ennis TL, Pagano MB, Thompson RW

Ann Vasc Surg. 2006 May; 20(3):360-8.

Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline. [Vascular. 2005]

Ding R, McGuinness CL, Burnand KG, Sullivan E, Smith A

Vascular. 2005 Sep-Oct; 13(5):290-7.
Review Anti-TNF-alpha therapies: the next generation. [Nat Rev Drug Discov. 2003]

Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL

Nat Rev Drug Discov. 2003 Sep; 2(9):736-46.

Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. [J Vasc Surg. 2005]

Dardik A, Yamashita A, Aziz F, Asada H, Sumpio BE

J Vasc Surg. 2005 Feb; 41(2):321-31.

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. [J Clin Invest. 2000]

Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW

J Clin Invest. 2000 Jun; 105(11):1641-9.
Review Mouse models of abdominal aortic aneurysms. [Arterioscler Thromb Vasc Biol. 2004]

Daugherty A, Cassis LA

Arterioscler Thromb Vasc Biol. 2004 Mar; 24(3):429-34.
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. [J Clin Invest. 2002]

Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT

J Clin Invest. 2002 Sep; 110(5):625-32.
Elastase-induced experimental aneurysms in rats. [Circulation. 1990]

Anidjar S, Salzmann JL, Gentric D, Lagneau P, Camilleri JP, Michel JB

Circulation. 1990 Sep; 82(3):973-81.
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. [J Clin Invest. 2000]

Daugherty A, Manning MW, Cassis LA

J Clin Invest. 2000 Jun; 105(11):1605-12.

In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. [Bone. 1998]

Greenwald RA, Golub LM, Ramamurthy NS, Chowdhury M, Moak SA, Sorsa T

Bone. 1998 Jan; 22(1):33-8.
The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. [J Periodontol. 1996]

Crout RJ, Lee HM, Schroeder K, Crout H, Ramamurthy NS, Wiener M, Golub LM

J Periodontol. 1996 May; 67(5):506-14.
A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. [Proc Natl Acad Sci U S A. 1996]

Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB

Proc Natl Acad Sci U S A. 1996 Nov 26; 93(24):14014-9.
Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. [J Vasc Surg. 2000]

Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, Sicard GA, Thompson RW

J Vasc Surg. 2000 Feb; 31(2):325-42.
A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. [J Dent Res. 1987]

Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS

J Dent Res. 1987 Aug; 66(8):1310-4.

Are there genes for aneurysm in the blueprint of the human genome? [Ann Vasc Surg. 2004]

Kuivaniemi H

Ann Vasc Surg. 2004 Jan; 18(1):2-3.
Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. [Circulation. 2004]

Shibamura H, Olson JM, van Vlijmen-Van Keulen C, Buxbaum SG, Dudek DM, Tromp G, Ogata T, Skunca M, Sakalihasan N, Pals G, Limet R, MacKean GL, Defawe O, Verloes A, Arthur C, Lossing AG, Burnett M, Sueda T, Kuivaniemi H

Circulation. 2004 May 4; 109(17):2103-8.
Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. [Nat Med. 2005]

Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, Esato K, Hamano K, Matsuzaki M

Nat Med. 2005 Dec; 11(12):1330-8.
Review Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? [Circ Res. 2001]

Creemers EE, Cleutjens JP, Smits JF, Daemen MJ

Circ Res. 2001 Aug 3; 89(3):201-10.
Review Matrix metalloproteinases and cardiovascular disease. [Circ Res. 1995]

Dollery CM, McEwan JR, Henney AM

Circ Res. 1995 Nov; 77(5):863-8.
Review Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. [Curr Vasc Pharmacol. 2005]

Boyle JJ

Curr Vasc Pharmacol. 2005 Jan; 3(1):63-8.
Review Matrix metalloproteinases and atherosclerosis. [Curr Atheroscler Rep. 2004]

Watanabe N, Ikeda U

Curr Atheroscler Rep. 2004 Mar; 6(2):112-20.
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. [J Neurosci. 2005]

Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, Lipton SA

J Neurosci. 2005 Jul 6; 25(27):6401-8.
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. [Stroke. 2005]

Rosell A, Alvarez-Sabín J, Arenillas JF, Rovira A, Delgado P, Fernández-Cadenas I, Penalba A, Molina CA, Montaner J

Stroke. 2005 Jul; 36(7):1415-20.
Review Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium. [Ann Med. 2001]

Wilson EM, Spinale FG

Ann Med. 2001 Dec; 33(9):623-34.
Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. [Circulation. 2002]

Chancey AL, Brower GL, Peterson JT, Janicki JS

Circulation. 2002 Apr 23; 105(16):1983-8.
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. [Cancer Res. 1993]

Zucker S, Lysik RM, Zarrabi MH, Moll U

Cancer Res. 1993 Jan 1; 53(1):140-6.
Review Osteoarthritis - an untreatable disease? [Nat Rev Drug Discov. 2005]

Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA

Nat Rev Drug Discov. 2005 Apr; 4(4):331-44.
Elevated plasma stromelysin levels in arthritis. [J Rheumatol. 1994]

Zucker S, Lysik RM, Zarrabi MH, Greenwald RA, Gruber B, Tickle SP, Baker TS, Docherty AJ

J Rheumatol. 1994 Dec; 21(12):2329-33.

You are here: NCBI > Literature > PubMed Central (PMC)

Write to the Help Desk

PMC

Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm

Abstract

Formats:

Related citations in PubMed

Cited by other articles in PMC

Links

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information